Jae Ro, MD, PhD

Professor of Pathology and Genomic Medicine, Institute for Academic Medicine
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College


After completing his fellowship at MD Anderson in the Department of Pathology; in 1985, he was named instructor in that department, and he was promoted to assistant professor, associate professor, and professor over the following 7 years. Dr. Ro left M. D. Anderson in 1998 to become Chairman and Director of the Department of Pathology at the Asan Medical Center, Ulsan University, Seoul, Korea, but returned the next year, assuming his past duties as Co-director of the Fellowship Training Program and Chief of Pulmonary and Mediastinal Pathology at the MD Anderson Cancer Center. He retired from MD Anderson in October 2001 and returned to the Asan Medical Center as a Chairman and Director of the Department of Pathology until he joined Houston Methodist Hospital in March, 2005.

Dr. Ro has served on many professional organizations, including the Korean-American Society of Pathology (for which he was chairman from 1996 to 1998), Korean Society of Pathology (for which he was vice-president from 2004-2005), American Society of Clinical Pathologists, College of American Pathologists, International Academy of Pathology and United States and Canadian Academy of Pathology. Dr. Ro has published over 500 papers in the highest quality peer reviewed journals and presented more than 400 abstracts at national and international scientific meetings. He also published one textbook and more than 20 book chapters and teaching manuals. He has served as a guest lecturer in the United States and abroad.

Description of Research

Dr. Ro’s main research interests include studies on the pathogenesis of genitourinary and lung tumors including prevention and the identification of prognostic factors. For these purposes, molecular and tissue microarray techniques have been used. These studies are primarily translational research, as his findings are based on surgical specimens submitted to Houston Methodist Hospital.

Areas Of Expertise

Genitourinary Lung, cancer Diagnosis Prognostic factors
Education & Training

Clinical Fellowship, The University of Texas MD Anderson Cancer Center
Residency, Case Western Reserve University
PhD, Medical College, Yonsei University, Seoul
MS, Medical College, Yonsei University, Seoul
MD, Medical College, Yonsei University, Seoul

Renal collision tumor composed of oncocytoma and mucinous tubular and spindle cell carcinoma: case report of an unprecedented entity
Arora, K, Miller, R, Mullick, S, Shen, S, Ayala, AG & Ro, JY 2018, Human Pathology, vol 71, pp. 60-64. DOI: 10.1016/j.humpath.2017.08.012

Sarcoid-like granulomas in renal cell carcinoma: The Houston Methodist Hospital experience
Arora, K, Divatia, MK, Truong, L, Shen, SS, Ayala, AG & Ro, JY 2017, Annals of Diagnostic Pathology, vol 31, pp. 62-65. DOI: 10.1016/j.anndiagpath.2017.07.003

Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma
Go, H, Kang, MJ, Kim, PJ, Lee, JL, Park, JY, Park, JM, Ro, JY & Cho, YM 2017, Pathology and Oncology Research, pp. 1-8. DOI: 10.1007/s12253-017-0323-2

Recent updates on grading and classification of neuroendocrine tumors
Kim, JY, Hong, SM & Ro, JY 2017, Annals of Diagnostic Pathology, vol 29, pp. 11-16. DOI: 10.1016/j.anndiagpath.2017.04.005

Primary collision tumors of the kidney composed of oncocytoma and papillary renal cell carcinoma: A review
McCroskey, Z, Sim, SJ, Selzman, AA, Ayala, AG & Ro, JY 2017, Annals of Diagnostic Pathology, vol 29, pp. 32-36. DOI: 10.1016/j.anndiagpath.2017.04.011

Level of mitoses in non-muscle invasive papillary urothelial carcinomas (pTa and pT1) at initial bladder biopsy is a simple and powerful predictor of clinical outcome: A multi-center study in South Korea
Kwon, JE, Cho, NH, Choi, YJ, Lim, SD, Cho, YM, Jun, SY, Park, S, Kim, YA, Kim, SS, Choe, MS, Lee, JD, Kang, DY, Ro, JY & Kim, HJ 2017, Diagnostic Pathology, vol 12, no. 1, 54. DOI: 10.1186/s13000-017-0639-y

Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-ß (PDGF-ß), and PDGF-ß receptor expression in papillary renal cell carcinoma
Kim, M, Sohn, M, Shim, M, Choi, SK, Park, M, Kim, E, Go, H, Park, Y, Cho, YM, Ro, JY, Jeong, IG, Song, C, Hong, JH, Kim, CS & Ahn, H 2017, Human Pathology, vol 61, pp. 78-89. DOI: 10.1016/j.humpath.2016.12.002

Clinicopathologic and molecular pathology of collecting duct carcinoma and related renal cell carcinomas
Seo, AN, Yoon, G & Ro, JY 2017, Advances in Anatomic Pathology, vol 24, no. 2, pp. 65-77. DOI: 10.1097/PAP.0000000000000138

Prognostic Significance of Macroscopic Appearance in Clear Cell Renal Cell Carcinoma and Its Metastasis-Predicting Model
Jeong, SU, Park, JM, Shin, SJ, Lee, J, Song, C, Go, H, Cho, NH, Ro, JY & Cho, YM 2017, Pathology International. DOI: 10.1111/pin.12606

An isolated inflammatory myofibroblastic tumor of adrenal gland
Al Sannaa, G, Wimmer, JL, Ayala, AG & Ro, JY 2016, Annals of Diagnostic Pathology, vol 25, pp. 33-36. DOI: 10.1016/j.anndiagpath.2016.04.011

Intraductal carcinoma of the prostate gland: Recent advances
Divatia, MK & Ro, JY 2016, Yonsei Medical Journal, vol 57, no. 5, pp. 1054-1062. DOI: 10.3349/ymj.2016.57.5.1054

Anaplastic Transformation of Papillary Thyroid Carcinoma Only Seen in Pleural Metastasis: A Case Report with Review of the Literature
Kim, H, Park, YW, Oh, YH, Sim, J, Ro, JY & Pyo, JY 2016, Head and Neck Pathology, pp. 1-6. DOI: 10.1007/s12105-016-0751-4

Correlation of Histologic Subtypes and Molecular Alterations in Pulmonary Adenocarcinoma: Therapeutic and Prognostic Implications
Kim, J, Jang, SJ, Choi, CM & Ro, JY 2016, Advances in Anatomic Pathology. DOI: 10.1097/PAP.0000000000000121

The 14th spring seminar of the Korean pathologists association of North America
Lee, EY, Yu, E & Ro, JY 2016, Archives of Pathology and Laboratory Medicine, vol 140, no. 5, pp. 394-396. DOI: 10.5858/arpa.2015-0381-ED

Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association with Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer
Park, IH, Kong, SY, Ro, JY, Kwon, Y, Kang, JH, Mo, HJ, Jung, SY, Lee, S, Lee, KS, Kang, HS, Lee, E, Joo, J & Ro, J 2016, Clinical Breast Cancer, vol 16, no. 1, pp. 51-58. DOI: 10.1016/j.clbc.2015.07.006

Adverse tissue reactions after total hip arthroplasty
Miller, RA, Ro, JY & Schwartz, MR 2016, Annals of Diagnostic Pathology. DOI: 10.1016/j.anndiagpath.2016.07.006

IgG4-related disease in a non-healing gastric ulcer: Case report
Moyer, AB, Schwartz, MR, Lim, S, Tompson, ML & Ro, JY 2016, International Journal of Clinical and Experimental Pathology, vol 9, no. 6, pp. 6588-6591.

Clear cell atypical fibroxanthoma arising from vaginal stump: A case report from unusual location with a history of radiation therapy
Yoo, SH, An, S, Kim, KR, Ro, JY & Song, JS 2016, International Journal of Clinical and Experimental Pathology, vol 9, no. 3, pp. 4049-4054.

Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy
Jeong, IGA, Dajani, D, Verghese, M, Hwang, J, Cho, YME, Hong, JHY, Kim, CS, Ahn, H & Ro, JY 2016, Urologic Oncology: Seminars and Original Investigations, vol 34, no. 1. DOI: 10.1016/j.urolonc.2015.08.004

Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy
Lee, D, Yoo, S, You, D, Hong, B, Cho, YM, Hong, JH, Kim, CS, Ahn, H, Ro, JY & Jeong, IG 2015, Urologic Oncology: Seminars and Original Investigations. DOI: 10.1016/j.urolonc.2016.06.021